Meridian Bioscience, Inc. Announces Two New Exclusive International Distribution Agreements in Australia and Argentina
CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced the commencement of two new exclusive international distribution agreements. In Australia, Meridian has signed with Immuno Pty, Ltd, based in Sydney. For Argentina, Meridian has signed with Scott Pharma. This decision is consistent with Meridian’s stated commitment to expand its non-US businesses.